Jandugan, Basilisa R.

HRN: 07-08-28  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/16/2026
CEFTRIAXONE 1G (VIAL)
04/16/2026
04/23/2026
IV
2g
OD
CAPMR, UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary TractPneumonia    Compliance to guidelines: